Breakwater Capital Group’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$304K Buy
+1,579
New +$170K 0.04% 320
2024
Q3
– Sell
-1,855
Closed -$220K – 291
2024
Q2
$220K Buy
+1,855
New +$235K 0.05% 259
2023
Q2
– Sell
-1,313
Closed -$202K – 204
2023
Q1
$202K Buy
+1,313
New +$217K 0.08% 181

Other funds holding MRNA

Breakwater Capital Group's MRNA Position: Q3 2026 in Review

Breakwater Capital Group opened a new position in Moderna (MRNA) in Q3 2026: 1,579 shares worth $304K. The stake represents 0.04% of the portfolio and ranks #320 among its holdings. This is a return to the name: Breakwater Capital Group previously reported a position in MRNA as recently as Q2 2024.

Breakwater Capital Group first reported a position in MRNA in Q1 2023 and has held it in 3 quarters since. 32 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Breakwater Capital Group held 1,579 shares of Moderna worth $304K as of Q3 2026.
  • Moderna was a new Breakwater Capital Group position in Q3 2026.
  • Moderna made up 0.04% of Breakwater Capital Group's portfolio in Q3 2026, its #320 holding.
  • Breakwater Capital Group first reported a position in Moderna in Q1 2023 and has held it in 3 quarters since.
  • 32 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Breakwater Capital Group's 13F filing for Q3 2026, filed 9 Oct 2026.